GlobalData on MSN
Actio doses first subject in trial of ABS-1230 for epilepsy
Actio Biosciences has administered the initial dose to a subject in the Phase Ia clinical trial of ABS-1230, a potassium ...
Vikram Rao, director of the UCSF Epilepsy Center, discusses why a third of seizure patients don’t respond to medication and the promising new surgical and technological treatments available.
It’s time to turn plans into action. Strategic investment and prioritization in epilepsy — as part of a holistic brain health ...
Epilepsy patients with versus without psychiatric comorbidities have a higher proportion of abnormal brain magnetic resonance ...
10don MSN
Breathing interruptions after seizures may be risk factor for unexpected death in epilepsy patients
Epilepsy patients who experience breathing interruptions after a seizure may be at a higher risk of sudden unexpected death ...
Sudden unexpected death in epilepsy (SUDEP) is the leading cause of epilepsy-related deaths in children and adults with ...
Patients with drug-resistant epilepsy who show no abnormalities on MRI are less likely to achieve seizure freedom following ...
Avon Lake City Council has unanimously passed a resolution to promote awareness and education surrounding sudden death in ...
Dozens of people are taking steps toward a world without seizures. Roughly 100 walkers made their way through Kirby Park in Wilkes-Barre on Saturday for the Annual Walk for Epilepsy. About one in 26 ...
HealthDay News — Just over half (55 percent) of pregnant women with epilepsy (WWE) saw a neurologist in the year prior to delivery, according to a study presented at the American Neurological ...
Support is on the rise following the death of a 14-year-old New Jersey boy. Nicholas M. Leonor, 14, of Somers Point, died ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results